Abstract | BACKGROUND AND OBJECTIVE: PATIENTS AND METHODS: RESULTS: CONCLUSION:
|
Authors | Arash Mozayan, Samer Farah |
Journal | Ophthalmic surgery, lasers & imaging retina
(Ophthalmic Surg Lasers Imaging Retina)
2013 Jan-Feb
Vol. 44
Issue 1
Pg. 25-7
ISSN: 2325-8179 [Electronic] United States |
PMID | 23418730
(Publication Type: Journal Article)
|
Copyright | Copyright 2013, SLACK Incorporated. |
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal, Humanized
- Glucocorticoids
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Bevacizumab
- Ranibizumab
|
Topics |
- Acute Disease
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors
(adverse effects)
- Antibodies, Monoclonal, Humanized
(adverse effects, therapeutic use)
- Bevacizumab
- Conjunctivitis
(chemically induced, diagnosis, drug therapy)
- Eye Pain
(chemically induced, diagnosis, drug therapy)
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Incidence
- Intravitreal Injections
- Iritis
(chemically induced, diagnosis, drug therapy)
- Photophobia
(chemically induced, diagnosis, drug therapy)
- Ranibizumab
- Retinal Diseases
(drug therapy)
- Retrospective Studies
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Visual Acuity
|